<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04806698</url>
  </required_header>
  <id_info>
    <org_study_id>MCOS7</org_study_id>
    <nct_id>NCT04806698</nct_id>
  </id_info>
  <brief_title>Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia</brief_title>
  <acronym>MCOS7</acronym>
  <official_title>Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Menicon Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Menicon Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the long-term efficacy of the Menicon Z Night orthokeratology contact lens in&#xD;
      controlling the progression of childhood myopia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, controlled, parallel, longitudinal study compared the axial length growth&#xD;
      of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a&#xD;
      control group over a 7-year period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2007</start_date>
  <completion_date type="Actual">March 1, 2015</completion_date>
  <primary_completion_date type="Actual">March 1, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Axial length</measure>
    <time_frame>Seven years</time_frame>
    <description>To compare the axial length growth of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a control group of distance, single vision glasses or soft contact lenses</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Myopia, Progressive</condition>
  <condition>Children, Only</condition>
  <arm_group>
    <arm_group_label>Menicon Z Night</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental arm includes a group of children wearing Menicon Z Night orthokeratology contact lenses for 7 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The active comparator arm includes a control group of children wearing distance, single-vision glasses or soft contact lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Menicon Z Night</intervention_name>
    <description>Children wearing Menicon Z Night orthokeratology contact lenses</description>
    <arm_group_label>Menicon Z Night</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Children wearing distance single-vision glasses or distance single-vision soft contact lenses</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be 6 to 12 years of age, both ages inclusive&#xD;
&#xD;
          -  A low-to-moderate level of myopia (between -0.75 and -4.00 D) and of astigmatism (≤&#xD;
             1.00 D)&#xD;
&#xD;
          -  Neophyte contact lens wearer&#xD;
&#xD;
          -  Be successfully fitted with spectacles or orthokeratology contact lenses&#xD;
&#xD;
          -  Be able to achieve, through spherical refraction correction, a logMAR visual acuity of&#xD;
             0.8 or better in each eye&#xD;
&#xD;
          -  Be willing and able to follow the subject instructions and to meet the&#xD;
             protocol-specified schedule of follow-up visits&#xD;
&#xD;
          -  White European ethnicity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic or ocular disease affecting ocular health&#xD;
&#xD;
          -  Use of any systemic or topical medications that could affect ocular physiology or&#xD;
             contact lens performance&#xD;
&#xD;
          -  Any lid or anterior segment abnormalities for which contact lens wear could be&#xD;
             contraindicated&#xD;
&#xD;
          -  CCLRU grade ≥ 2 for any given anterior segment ocular clinical signs&#xD;
&#xD;
          -  Aphakic, amblyopic, and atopic individuals&#xD;
&#xD;
          -  Refractive astigmatism ≥ ½ spherical refraction&#xD;
&#xD;
          -  Previous contact lens wear&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>White European</gender_description>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R, Sugimoto K. Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia. Curr Eye Res. 2017 May;42(5):713-720. doi: 10.1080/02713683.2016.1221979. Epub 2016 Oct 21.</citation>
    <PMID>27767354</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Myopia, Degenerative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

